Zhitong Finance App News, Kaisa Health (00876.HK) announced that Qinghai Pharmaceutical Co., Ltd. (Qinghai Pharmaceuticals), a subsidiary of the Group, has successfully obtained the “Drug Registration Certificate” issued by the China National Drug Administration (NDRA) on July 21, 2026, and has been approved for domestic production registration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.